Scarica l'app Stockscreener
1.61
2.42%
-0.04
Precedente Chiudi:
$1.65
Aprire:
$1.61
Volume 24 ore:
160.49K
Relative Volume:
0.60
Capitalizzazione di mercato:
$8.10M
Reddito:
$5.64M
Utile/perdita netta:
$-23.88M
Rapporto P/E:
-2.9273
EPS:
-0.55
Flusso di cassa netto:
$-22.36M
1 W Prestazione:
-8.00%
1M Prestazione:
-37.60%
6M Prestazione:
-77.79%
1 anno Prestazione:
-74.44%
Intervallo 1D:
$1.44
$1.64
Intervallo di 1 settimana:
$1.44
$1.78
Portata 52W:
$1.44
$10.40
Evogene Ltd Stock (EVGN) Company Profile
Confronta EVGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| EVGN | 1.59 | 8.10M | 5.64M | -23.88M | -22.36M | -0.55 |
| VRTX | 449.73 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 746.81 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 594.32 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.52 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.01 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-10-08 | Iniziato | ROTH Capital | Buy |
| 2021-07-29 | Iniziato | Aegis Capital | Buy |
| 2020-12-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2013-12-16 | Iniziato | Oppenheimer | Outperform |
Evogene Ltd Borsa (EVGN) Ultime notizie
Evogene earnings missed by $0.30, revenue fell short of estimates - Investing.com India
Evogene Sees Revenue Growth and Expands AI Collaboration - TipRanks
SEC Form 424B3 filed by Evogene Ltd - Quantisnow
Evogene Reports Third Quarter 2024 Financial Results - Yahoo Canada Finance
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results - Marketscreener.com
Evogene's Bio-Fungicide Shows 70% Efficacy in Trials, Advances to Pre-Commercial Stage | EVGN Stock News - StockTitan
Evogene stock hits 52-week low at $1.7 amid market challenges - Investing.com India
Evogene subsidiary Lavie Bio announces commercial expansion of Yalos treatment - TipRanks
Finansavisen - Finansavisen
Evogene Schedules Third Quarter 2024 Financial Results Release - Marketscreener.com
Evogene (EVGN) to Report Q3 2024 Results, Hosts Virtual Conference Call Nov 21 | EVGN Stock News - StockTitan
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design - Krishak Jagat English
Evogene and Google Cloud Partner to Develop AI Foundation Model for Drug Discovery - HIT Consultant
Evogene stock hits 52-week low at $2.13 amid market challenges - Investing.com Australia
500: Something went wrong - Investing.com
Evogene partners with Google Cloud for AI-driven molecule design By Investing.com - Investing.com Australia
Evogene partners with Google Cloud for AI-driven molecule design - Investing.com India
Biomica to Present at Digestive Disease Week (DDW) Conference 20 - GuruFocus.com
Evogene announces collaboration with Google Cloud - MSN
Syngenta and Lavie Bio Announce Partnership to Discover and Deve - GuruFocus.com
Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya - Krishak Jagat English
Evogene Ltd. (NASDAQ:EVGN) Sees Significant Growth in Short Interest - MarketBeat
Evogene (NASDAQ:EVGN) Stock Crosses Below 200-Day Moving AverageShould You Sell? - MarketBeat
StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN) - MarketBeat
Evogene stock hits 52-week low at $2.21 amid market challenges - Investing.com Nigeria
Evogene (NASDAQ:EVGN) Coverage Initiated by Analysts at StockNews.com - MarketBeat
Watershed, Evogene, and BGU to Expand Gene Editing Applications to White Leg Shrimp and Red Swamp Crayfish - ISAAA
Evogene (NASDAQ:EVGN) Shares Pass Below Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Evogene (NASDAQ:EVGN) Research Coverage Started at StockNews.com - MarketBeat
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology - PR Newswire
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of ‘MicroFermentor’, a Unique Technology that Can Change the Economics of Ag-Biologicals - Krishak Jagat English
Lavie Bio receives grant to advance ag-biologicals tech - World Bio Market Insights
Evogene (NASDAQ:EVGN) Stock Price Crosses Below 200 Day Moving Average of $5.81 - MarketBeat
StockNews.com Initiates Coverage on Evogene (NASDAQ:EVGN) - MarketBeat
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals - Lelezard
Evogene receives grant from IIA to advance development of ‘MicroFermentor’ - TipRanks
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals – Company AnnouncementFT.com - Financial Times
Evogene stock hits 52-week low at $2.6 amid market challenges - Investing.com Canada
Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories - GuruFocus.com
Biomica CEO Set to Attend JP Morgan Healthcare Week in San Franc - GuruFocus.com
Casterra Appoints New CEO and Expands Team to Drive Growth and I - GuruFocus.com
A Tale of Resilience: Evolv Technologies Holdings Inc Amid Stock Market Turbulence - The InvestChronicle
Evogene Ltd Azioni (EVGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.80%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):